A scientist uses a magnifying glass to observe a man at a desk.

Scientists leverage the massive amounts of data companies accumulate to identify biomarkers and predict viral infections.

Credit: iStock/Stan Eales

Genetic discrimination and Snapchat

What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?
Natalya Ortolano, PhD Headshot
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Some friends recently convinced me to download an app I hadn’t used in nearly a decade: Snapchat. I questioned my decision almost immediately when I saw how closely Snapchat tracked my location. Some of my friends, to their surprise, did not have their location data private. I could see not only the address where they were, but the exact area within the building. I quickly turned off my location data and wondered if I should delete the app until a friend suggested that sharing my location with select people could be beneficial. If we were separated in a crowded place or I went missing, she could see my last location. 

The massive amount of data that companies collect — with or without our knowledge — is overwhelming and disconcerting to many. But sometimes we voluntarily provide detailed, personal information to companies. Everyday, hundreds of people spit into a tube, package it in a brown envelope, and ship it to 23andMe to learn about their ancestry and disease risks. 

Researchers at 23andMe leverage this data to predict and treat diseases such as COVID-19. They use their massive sequencing datasets to find clinically relevant mutations. For example, they recently surveyed customers who had COVID-19 about their symptom severity and identified a point mutation associated with COVID-19-induced loss of smell. 

“These patients are absolutely miserable,” said David Rosen, an otolaryngologist developing treatments for COVID-19 induced smell loss. They can’t smell [or taste] food.” 

The new insights garnered by 23andMe researchers could help scientists find new treatments for COVID-19 related loss of smell.

Just like with Snapchat, sharing genomic data comes with risks, and people sometimes hesitate to undergo genetic testing, even in the clinic. While predicting disease based on associated mutations can help drug development and research move forward, it could also cause patients undue stress if they worry about developing life threatening diseases. Although the Genetic Information Nondiscrimination Act passed in 2008 prevents health insurance companies and employers from discriminating against people based on their genetic information, there are no guarantees that other forms of discrimination won’t turn up in the future.

It's important moving forward to ensure that individuals have control over who does and does not see their genetic data — just like their location data — because genetic discrimination is still uncharted territory.

About the Author

  • Natalya Ortolano, PhD Headshot

    Natalya received her PhD in from Vanderbilt University in 2021; she joined the DDN team the same week she defended her thesis. Her work has been featured at STAT News, Vanderbilt Magazine, and Scientific American. As an assistant editor, she writes and edits online and print stories on topics ranging from cows to psychedelics. Outside of work you can probably find her at a concert in her hometown Nashville, TN.

Related Topics

Published In

July/August 2022 : Volume 18 : Issue 7
Volume 18 - Issue 7 | July/August 2022

July/August 2022

July/August 2022 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist wearing gloves handles a pipette over a petri dish and a color-coded microplate in a laboratory setting.

The unsung tools behind analytical testing success

Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
A 3D rendering of motor neurons lit up with blue, purple, orange, and green coloring showing synapses against a black background.

Improving ALS research with pluripotent stem cell-derived models 

Discover new advancements in modeling amyotrophic lateral sclerosis.

Automating 3D cell selection

Discover precise automated tools for organoid and spheroid handling. 
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue